Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Horstmann

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Haematologica|April 12, 2012
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemiaLinda Zuurbier, Emanuel F Petricoin, Maartje J Vuerhard, et al.
BMC Genomic Data|April 19, 2022
An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapseLorenz Bartsch, Michael P Schroeder, Sonja Hänzelmann, et al.
Haematologica|August 27, 2013
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptorsLinda Zuurbier, Alejandro Gutierrez, Charles G Mullighan, et al.
Cell|June 28, 2002
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viabilityGaël G McGill, Martin Horstmann, Hans R Widlund, et al.
Blood|February 27, 2008
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, et al.
Blood|January 4, 2008
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosisBrian V Balgobind, Pieter Van Vlierberghe, Ans M W van den Ouweland, et al.
Haematologica|September 8, 2006
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocolsMartine van Grotel, Jules P P Meijerink, H Berna Beverloo, et al.
Plos Medicine|December 21, 2016
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyYunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, et al.
Translational Oncology|March 17, 2019
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic LeukemiaBruno A Lopes, Claus Meyer, Thayana C Barbosa, et al.
Nature Genetics|September 6, 2011
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemiaPriscila P Zenatti, Daniel Ribeiro, Wenqing Li, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Haematologica|April 12, 2012
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemiaLinda Zuurbier, Emanuel F Petricoin, Maartje J Vuerhard, et al.
BMC Genomic Data|April 19, 2022
An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapseLorenz Bartsch, Michael P Schroeder, Sonja Hänzelmann, et al.
Haematologica|August 27, 2013
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptorsLinda Zuurbier, Alejandro Gutierrez, Charles G Mullighan, et al.
Cell|June 28, 2002
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viabilityGaël G McGill, Martin Horstmann, Hans R Widlund, et al.
Blood|February 27, 2008
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaPieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, et al.
Blood|January 4, 2008
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosisBrian V Balgobind, Pieter Van Vlierberghe, Ans M W van den Ouweland, et al.
Haematologica|September 8, 2006
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocolsMartine van Grotel, Jules P P Meijerink, H Berna Beverloo, et al.
Plos Medicine|December 21, 2016
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyYunlei Li, Jessica G C A M Buijs-Gladdines, Kirsten Canté-Barrett, et al.
Translational Oncology|March 17, 2019
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic LeukemiaBruno A Lopes, Claus Meyer, Thayana C Barbosa, et al.
Nature Genetics|September 6, 2011
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemiaPriscila P Zenatti, Daniel Ribeiro, Wenqing Li, et al.
Pageof 5